Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions |
Total |
Series A Preferred Stock |
Series B Preferred Stock |
Preferred Stock Issued and Outstanding |
Common Stock Issued and Outstanding |
Common Stock Issued and Outstanding
Series A Preferred Stock
|
Common Stock Issued and Outstanding
Series B Preferred Stock
|
Additional Paid-In Capital |
Additional Paid-In Capital
Series B Preferred Stock
|
(Accumulated Deficit) Retained Earnings |
(Accumulated Deficit) Retained Earnings
Series B Preferred Stock
|
Accumulated Other Comprehensive Loss |
| Preferred stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
$ 2,071
|
|
|
$ 0
|
$ 0
|
|
|
$ 2,572
|
|
$ (11)
|
|
$ (490)
|
| Common stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
353,362,974
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income |
45
|
|
|
|
|
|
|
|
|
45
|
|
|
| Fair value change - derivatives |
13
|
|
|
|
|
|
|
|
|
|
|
13
|
| Foreign currency translation adjustment |
(42)
|
|
|
|
|
|
|
|
|
|
|
(42)
|
| Gain on dedesignated derivatives amortized from AOCI into income |
(4)
|
|
|
|
|
|
|
|
|
|
|
(4)
|
| Stock dividends (in shares) |
|
|
|
|
|
11,916,156
|
930,360
|
|
|
|
|
|
| Series B Preferred Stock dividend |
|
|
$ 0
|
|
|
|
|
|
$ 7
|
|
$ (7)
|
|
| Conversion of Series B Preferred Stock, net (in shares) |
|
|
|
|
24,390,245
|
|
|
|
|
|
|
|
| Conversion of Series B Preferred Stock, net |
197
|
|
|
|
|
|
|
214
|
|
(17)
|
|
|
| Profit sharing plan contributions (in shares) |
|
|
|
|
765,479
|
|
|
|
|
|
|
|
| Profit sharing plan contributions |
18
|
|
|
|
|
|
|
18
|
|
|
|
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
1,090,214
|
|
|
|
|
|
|
|
| Share-based compensation and other, net |
3
|
|
|
|
|
|
|
3
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Mar. 31, 2024 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2024 |
2,301
|
|
|
$ 0
|
$ 0
|
|
|
2,814
|
|
10
|
|
(523)
|
| Common stock, ending balance (in shares) at Mar. 31, 2024 |
|
|
|
|
392,455,428
|
|
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
2,071
|
|
|
$ 0
|
$ 0
|
|
|
2,572
|
|
(11)
|
|
(490)
|
| Common stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
353,362,974
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income |
183
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value change - derivatives |
(5)
|
|
|
|
|
|
|
|
|
|
|
|
| Foreign currency translation adjustment |
26
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Sep. 30, 2024 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Ending balance at Sep. 30, 2024 |
2,967
|
|
|
$ 0
|
$ 0
|
|
|
3,300
|
|
148
|
|
(481)
|
| Common stock, ending balance (in shares) at Sep. 30, 2024 |
|
|
|
|
412,142,330
|
|
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
$ 2,071
|
|
|
$ 0
|
$ 0
|
|
|
2,572
|
|
(11)
|
|
(490)
|
| Common stock, beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
353,362,974
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock dividends (in shares) |
11,916,156
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Dec. 31, 2024 |
|
4,000,000
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Ending balance at Dec. 31, 2024 |
$ 2,953
|
|
|
$ 0
|
$ 0
|
|
|
3,305
|
|
215
|
|
(567)
|
| Common stock, ending balance (in shares) at Dec. 31, 2024 |
|
|
|
|
412,167,491
|
|
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Mar. 31, 2024 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2024 |
2,301
|
|
|
$ 0
|
$ 0
|
|
|
2,814
|
|
10
|
|
(523)
|
| Common stock, beginning balance (in shares) at Mar. 31, 2024 |
|
|
|
|
392,455,428
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income |
69
|
|
|
|
|
|
|
|
|
69
|
|
|
| Fair value change - derivatives |
4
|
|
|
|
|
|
|
|
|
|
|
4
|
| Foreign currency translation adjustment |
(1)
|
|
|
|
|
|
|
|
|
|
|
(1)
|
| Gain on dedesignated derivatives amortized from AOCI into income |
(4)
|
|
|
|
|
|
|
|
|
|
|
(4)
|
| Issuance of common shares (shares) |
|
|
|
|
18,975,000
|
|
|
|
|
|
|
|
| Issuance of common shares |
458
|
|
|
|
|
|
|
458
|
|
|
|
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
49,053
|
|
|
|
|
|
|
|
| Share-based compensation and other, net |
8
|
|
|
|
|
|
|
8
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Jun. 30, 2024 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2024 |
2,835
|
|
|
$ 0
|
$ 0
|
|
|
3,280
|
|
79
|
|
(524)
|
| Common stock, ending balance (in shares) at Jun. 30, 2024 |
|
|
|
|
411,479,481
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income |
69
|
|
|
|
|
|
|
|
|
69
|
|
|
| Fair value change - derivatives |
(22)
|
|
|
|
|
|
|
|
|
|
|
(22)
|
| Foreign currency translation adjustment |
69
|
|
|
|
|
|
|
|
|
|
|
69
|
| Gain on dedesignated derivatives amortized from AOCI into income |
(4)
|
|
|
|
|
|
|
|
|
|
|
(4)
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
662,849
|
|
|
|
|
|
|
|
| Share-based compensation and other, net |
20
|
|
|
|
|
|
|
20
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Sep. 30, 2024 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Ending balance at Sep. 30, 2024 |
2,967
|
|
|
$ 0
|
$ 0
|
|
|
3,300
|
|
148
|
|
(481)
|
| Common stock, ending balance (in shares) at Sep. 30, 2024 |
|
|
|
|
412,142,330
|
|
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Dec. 31, 2024 |
|
4,000,000
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
2,953
|
|
|
$ 0
|
$ 0
|
|
|
3,305
|
|
215
|
|
(567)
|
| Common stock, beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
412,167,491
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income |
35
|
|
|
|
|
|
|
|
|
35
|
|
|
| Fair value change - derivatives |
(12)
|
|
|
|
|
|
|
|
|
|
|
(12)
|
| Foreign currency translation adjustment |
59
|
|
|
|
|
|
|
|
|
|
|
59
|
| Stock dividends (in shares) |
|
|
|
|
|
3,815,493
|
|
|
|
|
|
|
| Share repurchases (in shares) |
|
|
|
|
(3,095,573)
|
|
|
|
|
|
|
|
| Share repurchases |
(75)
|
|
|
|
|
|
|
(75)
|
|
|
|
|
| Profit sharing plan contributions (in shares) |
|
|
|
|
928,483
|
|
|
|
|
|
|
|
| Profit sharing plan contributions |
24
|
|
|
|
|
|
|
24
|
|
|
|
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
1,444,040
|
|
|
|
|
|
|
|
| Share-based compensation and other, net |
(2)
|
|
|
|
|
|
|
(2)
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Mar. 31, 2025 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
2,982
|
|
|
$ 0
|
$ 0
|
|
|
3,252
|
|
250
|
|
(520)
|
| Common stock, ending balance (in shares) at Mar. 31, 2025 |
|
|
|
|
415,259,934
|
|
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Dec. 31, 2024 |
|
4,000,000
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
2,953
|
|
|
$ 0
|
$ 0
|
|
|
3,305
|
|
215
|
|
(567)
|
| Common stock, beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
412,167,491
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income |
205
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value change - derivatives |
(33)
|
|
|
|
|
|
|
|
|
|
|
|
| Foreign currency translation adjustment |
172
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Sep. 30, 2025 |
|
4,000,000
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
3,276
|
|
|
$ 0
|
$ 0
|
|
|
3,284
|
|
420
|
|
(428)
|
| Common stock, ending balance (in shares) at Sep. 30, 2025 |
|
|
|
|
415,905,916
|
|
|
|
|
|
|
|
| Preferred stock, beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
2,982
|
|
|
$ 0
|
$ 0
|
|
|
3,252
|
|
250
|
|
(520)
|
| Common stock, beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
|
415,259,934
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income |
77
|
|
|
|
|
|
|
|
|
77
|
|
|
| Fair value change - derivatives |
(26)
|
|
|
|
|
|
|
|
|
|
|
(26)
|
| Foreign currency translation adjustment |
128
|
|
|
|
|
|
|
|
|
|
|
128
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
64,719
|
|
|
|
|
|
|
|
| Share-based compensation and other, net |
10
|
|
|
|
|
|
|
10
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Jun. 30, 2025 |
|
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
3,171
|
|
|
$ 0
|
$ 0
|
|
|
3,262
|
|
327
|
|
(418)
|
| Common stock, ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
415,324,653
|
|
|
|
|
|
|
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
|
| Net income |
93
|
|
|
|
|
|
|
|
|
|
|
|
| Fair value change - derivatives |
5
|
|
|
|
|
|
|
|
|
|
|
5
|
| Foreign currency translation adjustment |
(15)
|
|
|
|
|
|
|
|
|
|
|
(15)
|
| Share-based compensation and other, net (in shares) |
|
|
|
|
581,263
|
|
|
|
|
|
|
|
| Share-based compensation and other, net |
22
|
|
|
|
|
|
|
22
|
|
|
|
|
| Preferred stock, ending balance (in shares) at Sep. 30, 2025 |
|
4,000,000
|
|
4,000,000
|
|
|
|
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
$ 3,276
|
|
|
$ 0
|
$ 0
|
|
|
$ 3,284
|
|
$ 420
|
|
$ (428)
|
| Common stock, ending balance (in shares) at Sep. 30, 2025 |
|
|
|
|
415,905,916
|
|
|
|
|
|
|
|